Monday, October 3, 2022


Biotechnology News Magazine

Daniel Kagan PhD Promoted to President at

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Daniel Kagan PhD will launch and grow’s new AI-powered biotech-as-a-serviceTM (BaaS) platform.

Daniel Kagan PhD will continue to lead the company’s operations and strategic partnering efforts.

With exceptional leadership, clear-sighted vision, and legendary work ethic, Daniel Kagan has helped the company take huge steps toward achieving its mission to empower scientists and make it possible to cure all human diseases by 2050.

Kagan joined in 2013 after an award-winning Ph.D. from UC San Diego’s powerhouse bioengineering program. As VP of Research and then COO, he has played a pivotal role in building into one of the country’s fastest-growing private companies.

Under his leadership sales have increased for 73 straight months, from $11M USD in 2015 to $265M USD in 2020.

Dan’s commitment to fostering and growing new leadership within has resulted in very low employee turnover. Reflecting his efforts, the company was recognized by Inc. magazine in 2018 and 2019 as one of “America’s Best Workplaces.”

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine